Vomiting Prevention in Children With Cancer
Pediatric Cancer | Chemotherapy Induced Nausea and Vomiting | Quality of Life (QOL)The goal of this single arm trial is to learn if a machine learning (ML) model predicting the risk of vomiting within the next 96 hours will impact vomiting outcomes in inpatient cancer pediatric patients.
The main questions it aims to answer are whether an ML model predicting the risk of vomiting within the next 96 hours will:
Primary
1\. Reduce the proportion with any vomiting within the 96-hour window
Secondary
1. Reduce the number of vomiting episodes
2. Increase the proportion receiving care pathway-consistent care
3. Impact on number of administrations and costs of antiemetic medications
Newly admitted participants will have a ML model predict the risk of vomiting within the next 96 hours according to their medical admission information. The prediction will be made at 8:30 AM following admission. Pharmacists will be charged with bringing information about patients' vomiting risk to the attention of the medical team and implementing interventions.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
0 and up
Participation Criteria
Inclusion Criteria:
* All pediatric patients admitted to the oncology service at SickKids
Exclusion Criteria:
* Pediatric patients admitted to the oncology service at SickKids that are discharged prior to prediction time
Study Location
The Hospital for Sick Children
The Hospital for Sick ChildrenToronto, Ontario
Canada
Contact Study Team
- Study Sponsored By
- The Hospital for Sick Children
- Participants Required
- More Information
- Study ID:
NCT06886451